Skip to main content

Table 2 Patient demographics

From: The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis

 

Overall, N = 1015

No self-reported anxiety/depression, n = 625

Self-reported anxiety/depression, n = 390

P-value (atest)

Patient age, years

 Mean (SD)

55.2 (14.1)

54.3 (14.6)

56.7 (13.1)

.012 (MW)

Gender, n (%)

 Female

733 (72.2)

431 (69.0)

302 (77.4)

.004 (FE)

Years since RA diagnosis

 Mean, years (SD)

7.5 (7.4)

6.7 (7.0)

8.7 (7.9)

.001 (MW)

bMissing, n

69

38

31

 

Current severity level, n (%)

 Mild

682 (67.2)

479 (76.6)

203 (52.1)

 

 Moderate

294 (29.0)

138 (22.1)

156 (40.0)

 

 Severe

39 (3.8)

8 (1.3)

31 (7.9)

<.001 (MW)

Current pain level (1–10)

 Mean (SD)

3.3 (2.0)

2.8 (1.7)

4.1 (2.2)

<.001 (MW)

On biologic therapy, n (%)

Receiving biologic therapy/on break but expected to restart

469 (46.2)

20 (2.0)

264 (42.2)

10 (1.6)

205 (52.6)

10 (2.6)

.002 (FE)

Discontinued biologic, n (%)

30 (3.0)

16 (2.6)

14 (3.6)

0.636 (PC)

  1. FE Fisher’s exact test; MW Mann-Whitney’s U test; PC Pearson’s Chi-square test; RA rheumatoid arthritis; SD standard deviation
  2. aIndicates statistical test performed
  3. bNumber of patients for whom data were not reported